Sify.com » Topics » Lipitor
Lipitor News
Indian drugmaker OK'd to launch generic Lipitor
India's largest maker of generic drugs won approval late Wednesday to sell a generic version of cholesterol blockbuster Lipitor. The world's top-selling drug ever lost U.S. patent protection earlier in the day.The U.S. Food and Drug Administration said it granted Ranbaxy Laboratories Ltd. approval to sell a generic verson of Pfizer Inc.'s Lipitor, called atorvastatin calcium. The last-minute decision
India's largest maker of generic drugs won approval late Wednesday to sell a generic version of cholesterol blockbuster Lipitor. The world's top-selling drug ever lost U.S. patent protection earlier in the day.The U.S. Food and Drug Administration said it granted Ranbaxy Laboratories Ltd. approval to sell a generic verson of Pfizer Inc.'s Lipitor, called atorvastatin calcium. The last-minute decision
Indian markets jump on global rally
The BSE Sensex gained nearly 600 points in opening trade on Thursday, joining a rally by foreign markets over a coordinated lowering of lending rates by global central banks to offset a liquidity crunch for European banks.
The BSE Sensex gained nearly 600 points in opening trade on Thursday, joining a rally by foreign markets over a coordinated lowering of lending rates by global central banks to offset a liquidity crunch for European banks.
Ranbaxy launches Lipitor generic
A last-minute marketing approval from the United States medicine regulator, Food and Drugs Administration (FDA), and a profit-sharing agreement with Israel's Teva have helped Ranbaxy launch the
A last-minute marketing approval from the United States medicine regulator, Food and Drugs Administration (FDA), and a profit-sharing agreement with Israel's Teva have helped Ranbaxy launch the
Foreign inflow hopes drive Sensex up, gains 2.2%
Indian shares surged 2.2 per cent on Thursday to their best close in two weeks, as investors bet on a revival in foreign fund buying after moves by six major central banks to boost cash supplies to
Ranbaxy approved to make first generic version of Lipitor
India's largest maker of generic drugs, Ranbaxy Laboratories Ltd has won US approval to sell a generic version of the world's top-selling cholesterol lowering drug Lipitor hours after it lost US patent protection.
India's largest maker of generic drugs, Ranbaxy Laboratories Ltd has won US approval to sell a generic version of the world's top-selling cholesterol lowering drug Lipitor hours after it lost US patent protection.
Sensex up over 400 points as bulls remain aggressive
Thanks to sustained buying across the board, the market, which rallied sharply on strong global cues this morning, remains high up in positive territory now. Amid easing worries about Eurozone debt
Thanks to sustained buying across the board, the market, which rallied sharply on strong global cues this morning, remains high up in positive territory now. Amid easing worries about Eurozone debt
© Copyright Sify Technologies Ltd, 1998-2011. All rights reserved. India News Portal, Sify.com hosted at SifyHosting India's first Level 3 Internet Data Centre.
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise
Site optimized for Internet Explorer 5.5 and above.
See Disclaimer |Privacy Policy &Parental Guidance on pornography |careers@sify |About Us |Feedback |Advertise